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Acetylated microtubules (AcMTs), a post-translationally modiﬁed form of microtubules, promote
polarized protein transport. Here we report that inﬂuenza A virus (IAV) induces the acetylation of
microtubules in epithelial cells. By employing speciﬁc inhibitors and siRNA we demonstrate Rho
GTPase-mediated downregulation of tubulin deacetylase activity in IAV-infected cells, resulting in
increased tubulin acetylation. Further, we demonstrate that depolymerization/deacetylation or
enhanced acetylation of microtubules decreased or increased, respectively, the release of virions
from infected cells. IAV assembly requires the polarized delivery of viral components to apical
plasma membrane. Our ﬁndings suggest the potential involvement of AcMTs in polarized trafﬁcking
of IAV components.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Cytoskeleton is actively involved in virus entry, assembly, and
release [1,2]. Cytoskeleton has been proposed to be involved in
inﬂuenza A virus (IAV) assembly too [3]; however, a precise role
of cytoskeletal elements is not understood. IAV causes an acute
febrile respiratory disease in humans. IAV, an enveloped virus, is
the prototype of family Orthomyxoviridae and possesses a
segmented negative-sense RNA genome [4]. It replicates in the
nucleus, assembles at the plasma membrane and is released by
budding [5]. IAV assembly requires the polarized delivery of viral
components to apical plasma membrane. IAV particle consist of
three major components: the viral envelope, matrix protein (M1),
and viral ribonucleoprotein (vRNP) core. During assembly, constit-
uents of viral envelope are directly transported to the plasma
membrane via exocytic pathway. However, transport mechanism
of M1 and vRNP to the plasma membrane is not fully understood.
The likely possibilities are that they use a piggy-back mechanismchemical Societies. Published by E
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Drive, SE, Albuquerque, NMon viral transmembrane proteins or cytoskeletal elements [3]. Pre-
viously, M1 and nucleoprotein (NP) of IAV were shown to interact
with actin ﬁlaments [6,7]. Recent reports have described the
association of vRNP with microtubules and incorporation of
a- and b-tubulin, the heterodimers of microtubules into IAV
particles [8–10]. Further, we recently have shown the cleavage of
tubulin deacetylase histone deacetylase 6 (HDAC6) by IAV-induced
caspase-3 in infected cells [11]. Microtubules-based transport
machinery helps many viruses to effect their movement within
the cell [2]. Our hypothesis is that IAV modulates the microtubule
cytoskeleton to facilitate the transport of viral components.
Therefore, we are investigating the modulation of microtubule
network and its signiﬁcance during IAV replication. Here, we show
that IAV induces the acetylation of a-tubulin in epithelial cells.2. Materials and methods
2.1. Cells, virus, and plasmids
Madin-Darby canine kidney (MDCK) and normal human bron-
chial epithelial (NHBE) (provided by Greg Conner, University of
Miami) cells were grown in MEM (Invitrogen) and BEGM (Lonza),
respectively. IAV (H1N1) New Caledonia strain was propagated in
embryonated chicken eggs and titrated on MDCK cells. Plasmid
pcDNA3 (Invitrogen) expressing human HDAC6 was provided by
Tso-Pang Yao (Duke University). HDAC6 (D1088E) mutant has been
described elsewhere [11].lsevier B.V. All rights reserved.
Fig. 1. IAV-infected cells contain elevated levels of AcTub and total a-tubulin.
MDCK cells were infected with IAV at MOI of 0.5. Cells were treated with 20 lMBIM
(a) or infected with UV-inactivated IAV (b) where indicated. At 24 hpi cells were
lysed and total cell lysates were resolved on SDS–PAGE, and indicated proteins were
detected by Western blotting. (c) Quantitation of increase in the amount of AcTub
and a-tubulin in infected cells. The intensity of AcTub, a-tubulin, and actin bands
was quantitated using Quantity One 4.0 software (Bio-Rad). The amount of AcTub
and a-tubulin was normalized with actin amount, and was considered a 1-fold
increase in uninfected (UNI) cells for comparisons to infected (INF) cells. Each bar
represents the mean ± standard deviation (S.D.) for three independent experiments.
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Cells were washed twice with phosphate-buffered saline (PBS).
Virus inoculum, diluted in PBS and supplemented with 3 lg/ml
trypsin was added to cells. After 1 h incubation at 37 C, inoculum
was removed and cells were washed once with PBS. Fresh MEM
was added and cells were incubated at 37 C for 24 h. In some
experiments, MEM supplemented with bisindolylmaleimide
(BIM), Clostridium difﬁcile toxin B (CdTB), nocodazole (Noc) (Calbio-
chem) or trichostatin A (TSA) (Sigma-Aldrich) was added to cells
after removing the inoculum and cells were incubated as above.
To inactivate IAV, inoculumwas exposed to 1–2 mJ of UV radiation.
For transfection, 2–3 lg plasmid DNA and 4–5 ll Lipofectamine
2000 (Invitrogen) were diluted separately in OptiMEM I (Invitro-
gen), mixed and incubated for 20–30 min at room temperature.
DNA-Lipofectamine complex was added to cells and cells were
incubated for 24 h at 37 C.
2.3. Western blotting
Cells were harvested, washed with PBS, and lysed in lysis buffer
(50 mM Tris, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% SDS, and
protease-inhibitor cocktail [Roche]). The whole cell lysate was re-
solved on 10% Bis–Tris or 7% Tris-acetate gels (Invitrogen) and pro-
teins were transferred to nitrocellulose membrane. Membrane was
probed with mouse anti-acetylated a-tubulin (anti-AcTub), anti-a-
tubulin (Sigma-Aldrich), anti-NP (Chemicon), anti-RhoA (Cytoskel-
eton Inc.) or rabbit anti-actin (Abcam), anti-HDAC6 (Santa Cruz)
primary antibodies followed by HRP-conjugated donkey anti-
mouse (Afﬁnity BioReagents) or anti-rabbit (Pierce) secondary
antibodies, respectively. Protein bands were developed with
chemiluminescent kit (Thermo). All the Western blotting steps
were performed at room temperature. To re-probe the same mem-
brane with another antibody, membrane was stripped with Re-
store buffer (Thermo) for 20–30 min at 37 C.
2.4. siRNA-mediated knockdown
Pre-designed target speciﬁc siRNA oligonucleotides against
HDAC6 (Catalogue No. sc-35544) and RhoA (Catalogue No. sc-
29471) genes were purchased from Santa Cruz Biotech. Oligonucle-
otides (50 nM) were transfected into cells using 2 ll Lipofectamine
RNAiMax (Invitrogen) as described above. After 24–48 h incuba-
tion at 37 C, cells were infected and analyzed by Western blotting
as above.
2.5. Real time RT-PCR
Cells were grown on transwell ﬁlters (Corning) and infected
from apical side. At 24 h post-infection (hpi), apical media was col-
lected and centrifuged at 2000g for 5 min. Viral RNA was then
isolated from the media by using QIAamp kit (Qiagen). A quantita-
tive real time RT-PCR assay was performed using viral RNA as a
template to amplify IAV M1 gene, in vitro transcribed M1 RNA
was used as standard. QuantiTect RT mix (Qiagen), RNA template,
M1 forward primer (AGATTGCCGACTCCCAGCATAAGT), reverse pri-
mer (TGTTCACTCGATCCAGCCATTTGC), and probe (56-FAM/AGAAC
AGAATGGTTCTGGCCAGCACT/3BHQ) were mixed and RT-PCR reac-
tion was run on ABI 7900 thermocycler.
2.6. Virions preparation
Cells were grown on transwell ﬁlters and infected from apical
side. At 24 hpi, apical media was collected, cleared off cell debris,
and layered on 30% sucrose-NTE (100 mM NaCl, 10 mM Tris, pH
7.4, 1 mM EDTA) cushion and centrifuged at 250 000g for 2 h at4 C in Beckman TLA55 rotor. The pellet was resuspended in sam-
ple buffer and analyzed by Western blotting.
3. Results
3.1. IAV-infected epithelial cells contain elevated levels of AcTub and
a-tubulin
We recently demonstrated the cleavage of HDAC6 by IAV-in-
duced caspase-3 in infected cells [11]. This indicated the potential
regulation of HDAC6 activity in IAV-infected cells. Because HDAC6
is a-tubulin deacetylase [12], we investigated the acetylation of a-
tubulin in IAV-infected cells. MDCK cells were infected with IAV,
and total cell lysates were analyzed by Western blotting. We dis-
covered that IAV-infected cells contained elevated level of AcTub
(Fig. 1a). Over 2.5-times more AcTub was detected in infected cell
lysate as compared to uninfected cell lysate (Fig. 1c). Interestingly,
elevated levels of total a-tubulin (Fig. 1a) and b-tubulin (not
shown) were also observed at the same time. Over 1.5-fold in-
crease in total a-tubulin level was observed in infected cells
(Fig. 1c), suggesting that IAV is potentially regulating the level of
total tubulin too. To conﬁrm these observations, levels of AcTub
and total a-tubulin were analyzed in cells infected with IAV in
the presence of BIM, an inhibitor of IAV replication [13] or with
UV-inactivated IAV. No increase was observed in the level of either
tubulin in BIM-treated infected cells (Fig. 1a) as well as cells in-
fected with UV-inactivated IAV (Fig. 1b), suggesting that a produc-
tive IAV infection is required. Primary NHBE cells, which are the
actual target of IAV in vivo, were used to further conﬁrm the obser-
vations made in MDCK cells. Likewise, NHBE cells also showed ele-
vated levels of acetylated and total a-tubulin after IAV infection
(data not shown).
3.2. Activity of tubulin deacetylase HDAC6 is potentially
downregulated in IAV-infected cells
To understand the mechanism of enhanced a-tubulin acetyla-
tion, cells were treated with TSA, an HDAC6 inhibitor [12]. As
expected, after TSA treatment uninfected cells showed an increase
in a-tubulin acetylation due to inhibition of HDAC6’s deacetylase
activity; however, TSA-induced increase in the acetylation of
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shown). This indicated that HDAC6 activity is potentially downreg-
ulated in infected cells, consequently resulting into elevated level
of AcTub. To conﬁrm this, expression of HDAC6 was knocked down
by siRNA before IAV infection. Like TSA treatment, uninfected cells
with reduced level of HDAC6 expression showed an increase in the
acetylation of a-tubulin (Fig. 2b). Similarly, acetylation of a-tubu-
lin was even higher in infected cells with knocked down expression
of HDAC6 (Fig. 2b). To conversely conﬁrm the downregulation of
HDAC6 activity in IAV-infected cells, deacetylation efﬁciency
of plasmid-expressed HDAC6 was compared in uninfected and
infected cells. Plasmid-expressed HDAC6 was signiﬁcantly
effective in deacetylating the AcTub in uninfected cells (Fig. 2c),
however, in infected cells, plasmid-expressed HDAC6 was moder-
ately effective in deacetylating the AcTub (Fig. 2d). Over 57% AcTub
was deacetylated by plasmid-expressed HDAC6 in uninfected cells
as compared to only 34% in IAV-infected cells (Fig. 2e). This data
further indicated that HDAC6 activity is downregulated in IAV-
infected cells. To assess whether caspase-mediated cleavage of
HDAC6 [11] is responsible for this, deacetylation of AcTub was
analyzed in infected cells overexpressing the cleavage-resistant
HDAC6 (D1088E) mutant. Like cleavage-sensitive wild type
HDAC6, cleavage-resistant HDAC6 (D1088E) mutant also deacety-
lated the AcTub to a similar degree (Fig. 2d), suggesting that
cleavage of HDAC6 by caspase-3 does not contribute to downregu-
lation of its activity.
3.3. Rho GTPase is potentially involved in the downregulation of
HDAC6 activity in IAV-infected cells
It has been demonstrated earlier that Rho GTPase regulates
deacetylation of a-tubulin via HDAC6 [14]. To assess Rho GTPase’s
role in the enhanced acetylation of a-tubulin in IAV-infected cells,
expression of Rho was knocked down by siRNA before infecting theFig. 2. (a) Schematic showing the effect of HDAC6 on AcTub. (b) siRNA-mediated knockd
cells. NHBE cells were transfected with control (CT) or HDAC6 (HD) siRNAs for 24 h, and t
or moderately deacetylated the a-tubulin in uninfected (UNI) (c) or infected (INF) (d) ce
expressing wild-type HDAC6 (HD) or HDAC6 (D1088E) mutant (MT). Cells then were inf
expressed HDAC6. The amount of AcTub was quantitated and normalized with actin as i
for comparisons to HDAC6-transfected cells. Each bar represents the mean ± S.D. for thrcells with IAV. Consistent with Rho-mediated regulation of HDAC6
activity, uninfected cells with depleted Rho expression showed an
increase in the acetylation of a-tubulin (Fig. 3b). Similarly, acetyla-
tion of a-tubulin was even higher in infected cells with knocked
down expression of Rho (Fig. 3b), indicating a Rho-mediated down-
regulation of HDAC6 activity in IAV-infected cells. Almost identical
results were obtained when infected cells were treated with CdTB,
an inhibitor of Rho activity (data not shown). To conversely con-
ﬁrm the involvement of Rho, infected cells were treated with
Noc, a microtubule depolymerizing drug, which also activates the
Rho activity [15]. We argued that if Rho is involved in the enhanced
acetylation of a-tubulin then Noc treatment should result in the
signiﬁcant deacetylation of a-tubulin due to activation of Rho
and subsequent activation of HDAC6. Indeed, Noc greatly dimin-
ished a-tubulin acetylation in uninfected cells (not shown). Simi-
larly, we could not detect the AcTub in Noc-treated infected cells
(Fig. 3c). Further, Noc signiﬁcantly reduced the TSA-induced acet-
ylation of a-tubulin in infected cells (Fig. 3d). Collectively, these
data suggest that a Rho-mediated pathway is involved in the en-
hanced acetylation of a-tubulin in IAV-infected cells.
3.4. Acetylation of microtubules affects the release of IAV from infected
cells
We next investigated the signiﬁcance of enhanced a-tubulin
acetylation during IAV replication. A time-course experiment re-
vealed that increase in the levels of AcTub and a-tubulin occur
simultaneously between 6 and 12 hpi and coincide with IAV
growth phase (data not shown). These data indicated the potential
role of acetylated microtubules (AcMTs) in IAV assembly. Because
microtubules are actively involved in the transport of viral compo-
nents [2], we anticipated the role of AcMTs in the transport of IAV
components and evaluated the effect of microtubule acetylation on
IAV release from infected cells. For this, cells grown on transwellown of HDAC6 expression further increased the acetylation of a-tubulin in infected
hen infected and analyzed as Fig. 1. (c and d) Plasmid-expressed HDAC6 signiﬁcantly
lls, respectively. MDCK cells were transfected with empty plasmid pcDNA3 (pc) or
ected and analyzed as Fig. 1. (e) Quantitation of deacetylation of AcTub by plasmid-
n Fig. 1c. AcTub amount detected in pcDNA3-transfected cells was considered 100%
ee independent experiments. NA, not applicable.
Fig. 3. (a) Schematic showing the effect of Rho on acetylation of a-tubulin. (b) siRNA-mediated knockdown of Rho expression further increased the acetylation of a-tubulin in
infected cells. MDCK cells were transfected with control (Cont) or Rho siRNAs for 48 h, and then infected and analyzed as Fig. 1. (c and d) Noc induces the deacetylation of
AcTub in infected cells. MDCK cells were infected and analyzed as Fig. 1. Noc (30 lM) and/or TSA (3 lM) were included in the medium where indicated. For presentation,
some lanes are joined together from different parts of the same blot. UNI, uninfected; INF, infected.
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RNA was isolated from the apical media collected from mock-trea-
ted, Noc-treated and TSA-treated infected cells and used as a tem-
plate to amplify IAV M1 gene using real time RT-PCR. More than 3-
fold reduction in M1 gene copies was detected in the apical media
of Noc-treated infected cells as compared to mock infection
(Fig. 4a). Conversely, over 3-fold increase in the M1 copy numbers
was detected in the apical media of TSA-treated infected cells as
compared to mock-treated cells (Fig. 4a). Almost identical resultsFig. 4. Depolymerization/deacetylation and enhanced acetylation of microtubules
decreased and increased, respectively, the release of IAV from infected cells. MDCK
cells were grown on transwell ﬁlters and infected with IAV at MOI of 0.1. Noc
(30 lM) or TSA (30 nM) was included in the medium where indicated. (a)
Quantitative real time RT-PCR of M1 gene was performed using the viral RNA
template isolated from apical media of mock-treated, Noc-treated or TSA-treated
infected cells. Each bar represents the mean ± S.D. for three independent infections.
(b) Released virions were isolated from apical media of mock-treated, Noc-treated
or TSA-treated infected cells by ultracentrifugation. Virions were resuspended
directly in sample loading buffer, resolved on SDS–PAGE, and detected by Western
blotting.were obtained when virions were sedimented by ultracentrifuga-
tion from the apical media of mock-treated, Noc-treated and
TSA-treated infected cells and detected by Western blotting using
anti-NP antibody (Fig. 4b). These data suggest that AcMTs are
potentially involved in the trafﬁcking of IAV components.
4. Discussion
We have shown here the upregulation of acetylation of a-tubu-
lin after IAV infection in non-polarized as well as polarized (not
shown) epithelial cells. Further, enhancement in the level of total
a-tubulin also was observed in IAV-infected cells. Because of the
potential involvement of AcMTs in the trafﬁcking of IAV compo-
nents we initially focused on understanding the mechanism of en-
hanced acetylation of a-tubulin. At this point, we do not know the
mechanism of elevated level of total tubulin in infected cells and
currently working on it. Increase in total tubulin level may not
be due to increased tubulin synthesis because IAV, mostly through
its NS1 protein has been shown to shut off host protein synthesis
[16]. In contrast, NS1 also has been shown to enhance the protein
translation [17]. Therefore, it is likely that IAV differentially regu-
lates the protein synthesis in infected cells though this needs to
be examined with respect to tubulin. Alternatively, IAV could be
regulating the stability of tubulin polypeptides in infected cells.
The siRNA-mediated knockdown and overexpression of HDAC6
suggested that HDAC6 activity was potentially downregulated in
infected cells, consequently resulting into elevated level of AcTub.
In addition, IAV may also be regulating the activity of a-tubulin
acetylase to enhance the level of AcTub. Because, there also was
a simultaneous increase in the level of total a-tubulin after IAV
infection it is possible that newly appeared a-tubulin was greatly
acetylated. In the future we may be able to test this event because,
at present, mechanism of a-tubulin acetylation is not understood.
The caspase-3-mediated cleavage of HDAC6 did not contribute to
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cleavage-resistant HDAC6s deacetylated the a-tubulin in infected
cells to similar extents when overexpressed. On the other hand, a
Rho-mediated regulation of HDAC6 activity was evident in IAV-in-
fected cells. Rho family GTPases, which include Rho, Rac, and
Cdc42, are activated from inactive GDP-bound to active GTP-bound
state in response to stimuli. The activated Rho GTPases act on
downstream effectors like p21-activated protein kinase, Rho-asso-
ciated coiled-coil-containing protein kinase, neuronal Wiskott-Al-
drich syndrome protein, mammalian diaphanous protein (mDia)
and regulate the organization of cytoskeletal elements. The addi-
tional enhancement of a-tubulin acetylation due to silencing of
Rho gene and abolition of acetylation in the presence of Rho acti-
vator Noc clearly suggest that Rho is potentially modulating the
HDAC6 activity in IAV-infected cells. At this point, however, we
do not knowwhich Rho effector is involved in the downstream sig-
naling and regulation of HDAC6 activity in IAV-infected cells. A
Rho-mDia-HDAC6 pathway has been shown to regulate the micro-
tubule acetylation in osteoclasts [14]. Future investigations will re-
veal the signaling mechanisms upstream and downstream of Rho
in IAV-infected cells. In addition, Rho also could be involved in in-
creased level of total a-tubulin because when expression of Rho
was repressed in uninfected cells the amount of a-tubulin consid-
erably went up (Fig. 3b); however, this observation needs further
investigations. On the other hand, repression (Fig. 2b) or overex-
pression (Fig. 2c and d) of HDAC6 did not alter the level of total
a-tubulin in either uninfected or infected cells as compared to
the respective controls.
For IAV assembly all viral components must be transported to
apical surface of plasma membrane. However, little is known about
the involvement of cellular pathways and mechanism of the trans-
port of vRNP and M1 to assembly site. Recent reports have demon-
strated the association of vRNP with the microtubules [8,9]
suggesting a role for microtubules in the transport of vRNPs, how-
ever, a potential mechanism remains to be elucidated. Acetylation
is one of the post-translational modiﬁcations of a-tubulin [18];
therefore, IAV is modulating the post-translational modiﬁcations
of microtubules in infected cells. This is a novel ﬁnding, which
could have implications in understanding the polarized transport
of IAV components to apical plasma membrane. Post-translational
modiﬁcations tend to stabilize the microtubules, which then pref-
erentially promote the polarized protein trafﬁcking [18]. Recently,
some viruses have been shown to modulate the acetylation of
microtubules to facilitate delivery of virions to subcellular replica-
tion sites [19–21]. We have demonstrated here the enhanced acet-
ylation of microtubules in IAV-infected cells, and decrease in the
release of virions due to microtubule depolymerization/deacetyla-
tion and an increase due to enhanced microtubule acetylation.
However, decrease in virions released after Noc treatment was
not signiﬁcantly higher. This suggests that without AcMTs, IAV
components would randomly diffuse in the cytoplasm of infected
cells and reach the plasma membrane in a non-polarized fashion,
likely resulting in reduced or inefﬁcient virion assembly and re-
lease. Future studies will elucidate the role of AcMTs in the polar-
ized trafﬁcking of IAV components.Acknowledgments
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